KalVista Pharmaceuticals achieves key goals in late-stage study for hereditary angioedema therapy, demonstrating significant efficacy of sebetralstat. FDA approval filing ...
Cadence Design Systems beats analyst expectations with Q4 earnings, reporting higher-than-expected earnings per share and revenue. Despite shares falling, the ...
Block Inc. receives positive assessment from Bernstein with increased EBITDA projections and improved operational discipline. Sustained growth expected.